Home

The role of mast cells in the pathogenesis of autoimmune thyroid diseases

Written by Zdor V.V., Geltser B.I., Markelova E.V.

  UDK: 616.411-097.3:612.018.2 DOI: 10.17238/PmJ1609-1175.2016.3.11–14 | Pages: 11–14 | Full text PDF | Open PDF 

Annotation:

This literature review describes the role of cells of innate immune system, mast cells, in the pathogenesis of autoimmune thyroid diseases. In recent years a large number of articles were about studying new immune properties of mast cells and, in particular, their effect on T-cells’ functions through secretion of various cytokines. However, the articles that have been analyzed do not fully clarify an assumed ability of mast cells to directly activate T-cells through autoantigen presentation. Possible MHC class II expression by mast cells also remains disputable. This review considers a hypothesis that mast cells can control functional activity of immune cells and thyroid, provided they have appropriate effect. At present this assumption is considered to be a mechanism that triggers the pathogenesis of autoimmune thyroid diseases.

Links to authors:

V.V. Zdor, B.I. Geltser, E.V. Markelova
Pacific State Medical University (2 Ostryakova Ave. Vladivostok 690950 Russian Federation)


1. Grave›s disease and endocrine ophthalmopathy / edited by I.I. Dedov, G.A. Melnichenko . М.: MAI-PRINT, 2012. 143 p.
2. Vorobyev S.L. Morphological diagnosis of thyroid diseases StP.: KOSTA, 2014. 104 p.
3. Dedov I.I., Troshina E.A., Yushkov P.V. [et al.]. Diagnostics of thyroid diseases: atlas. М: Vidar-M, 2001. 128 p.
4. Emelyanov D.N., Sharaevskaya M.V., Smirnova T.S. [et al.]. Morphological and functional features of thyroid at chronical stress // Advances in current natural sciences. 2008. No. 12. P. 22.
5. Zdor V.V., Tikhonov Ya.N. Immune and histological changes in the glands of internal secretion in experimental hyperthyroidism and hypothyroidism // Clinical and experimental thyroidology. 2014. No. 1. P. 55–60. DOI: 10.14341/cet201410155-60.6. Paltsev M.A., Ivanov A.A. Cellular communication. М.: Meditsina, 1995. 224 p.
7. Fadeev V.V. Grave›s disease // Russian Medical Journal. 2002. Vol. 10, No. 11. P. 513–516.
8. Khmelnirskiy O.K. Cytological and histological diagnostics of thyroid diseases. StP.: SOTIS, 2002. 288 p.
9. Shumatov V.B., Pavlov V.A., Gorozhin P.Yu. [et al.]. The value of the pleiotropic effects of vitamin D after shock with severe concomitant injury// Pacific Medical Journal. 2016. No. 1. P. 9–13.
10. Yarilin A.A. Immunology: textbook. М.: GEOTAR-Media, 2010. 752 p.
11. Aich A., Afrin L.B., Gupta K. Mast cell-mediated mechanisms of nociception // Int. J. Mol. Sci. 2015. Vol. 16, No. 12. P. 29069– 29092. DOI: 10.3390/ijms161226151. PMCID: PMC4691098.
12. Ajjan R.A., Weetman A.P. The pathogenesis of Hashimoto›s thyroiditis: further developments in our understanding // Horm. Metab. Res. 2015. Vol. 47, No. 10. P. 702–710. DOI: 10.1055/s- 0035-1548832.
13. Baram D., Vaday G. G., Salamon P. [et al.]. Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-α // Journal of Immunology. 2001. Vol. 167, No. 7. P. 4008–4016. DOI: 10.4049/jimmunol.167.7.4008.
14. Brown M.A., Tanzola M.B., Robbie-Ryan M. Mechanisms underlying mast cell influence on EAE disease course // Mol. Immunol. 2002. Vol. 38. P. 1373–1378.
15. Chinenov Y., Gupte R., Rogatsky I.. Nuclear receptors in inflammation control: repression by GR and beyond // Mol. Cell Endocrinol. 2013. Vol. 380. P. 55–64. DOI: 10.1016/j.mce.2013.04.006. PMCID: PMC3787948. NIHMSID: NIHMS472979.
16. Da Silva E.Z., Jamur M.C., Oliver C. Mast cell function: a new vision of an old cell // Journal of Histochemistry–Cytochemistry. 2014. Vol. 62, No. 10. P. 698–738. DOI: 10.1369/0022155414545334.
17. Esposito I., Friess H., Kappeler A. [et al.]. Mast cell distribution and activation in chronic pancreatitis // Human Pathology. 2001. Vol. 32, No. 11. P. 1174–1183. DOI: 10.1053/hupa.2001.28947.
18. Esposito I., Kleeff J., Bischoff S. C. [et al.]. The stem cell factorc- kit system and mast cells in human pancreatic cancer // Laboratory Investigation. 2002. Vol. 82, No. 11. P. 1481–1492. DOI: 10.1097/01.lab.0000036875.21209.f9.
19. Geoffrey R., Jia S., Kwitek A. E. [et al.]. Evidence of a functional role for mast cells in the development of type 1 diabetes mellitus in the biobreeding rat // Journal of Immunology. 2006. Vol. 177, No. 10. P. 7275–7286. DOI: 10.4049/jimmunol.177.10.7275.
20. Gilfillan A.M., Beaven M.A. Regulation of mast cell responses in health and disease // Crit. Rev. Immunol. 2011. Vol. 31, No. 6. P. 475–529. PMCID: PMC3395887. NIHMSID: NIHMS389441.
21. Gregory G.D., Brown M.A. Mast cells in allergy and autoimmunity: implications for adaptive immunity // Methods in Molecular Biology. 2006, Vol. 315. P. 35–50. PMID: 16110147.
22. Gri G., Piconese S., Frossi B. [et al.]. CD4+ CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction // Immunity. 2008. Vol. 29, No. 5. P. 771–781. DOI: 10.1016/j.immuni.2008.08.018.
23. Han S.J., Lonard D.M., O›Malley B.W. Multi-modulation of nuclear receptor coactivators through posttranslational modifications // Trends Endocrinol. Metab. 2009. Vol. 20, No. 1. P. 8–15. DOI:
10.1016/j.tem.2008.10.001. PMCID: PMC3642869.
24. Hargreaves D.C., Horng T., Medzhitov R. Control of inducible gene expression by signal-dependent transcriptional elongation // Cell. 2009. Vol. 138, No. 1. P. 129–145. DOI: 10.1016/j. cell.2009.05.047.
25. Kambayashi T., Allenspach E.J., Chang J.T. [et al.]. Inducible MHC class II expression by mast cells supports effector and regulatory T cell activation // J. Immunol. 2009. Vol. 182, No. 8. P. 4686–4695. DOI: 10.4049/jimmunol.0803180.
26. Kaur D., Brightling C. OX40/OX40 ligand interactions in T-cell regulation and asthma // Chest. 2012. Vol. 141, No. 2. P. 494–499. DOI: 10.1378/chest.11-1730. PMID 22315115.
27. Lee H.J., Li C.W., Hammerstad S.S. [et al.]. Immunogenetics of autoimmune thyroid diseases: a comprehensive review // J. Autoimmun. 2015. DOI: 10.1016/j.jaut.2015.07.009.
28. Lu L.F., Lind E.F., Gondek D.C. [et al.]. Mast cells are essential intermediaries in regulatory T-cell tolerance // Nature. 2006. Vol. 442. P. 997–1002.
29. Malbec O., Daëron M. The mast cell IgG receptors and their roles in tissue inflammation // Immunological Reviews. 2007. Vol. 217, No. 1. P. 206–221. DOI: 10.1111/j.1600-065x.2007.00510.x.
30. Petra A.I., Panagiotidou S., Stewart J.M. [et al.]. Spectrum of mast cell activation disorders // Expert. Rev. Clin. Immunol. 2014. Vol. 10, No. 6. P. 729–739. DOI: 10,1586/1744666X.2014.906302.
31. Piconese S., Gri G., Tripodo C. [et al.]. Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation // Blood. 2009. Vol. 114, No. 13. P. 2639–2648. DOI: 10.1182/blood-2009-05-220004.
32. Rajković V., Matavulj M., Lukac T. [et al.]. Morphophysiological status of rat thyroid gland after subchronic exposure to low frequency electromagnetic field // Med. Pregl. 2001. Vol. 54, No. 3–4. P. 119–127. PMID: 11759202.
33. Rao K.N., Brown M.A. Mast cells: multifaceted immune cells with diverse roles in health and disease // Annals of the New York Academy of Sciences. 2008. Vol. 1143. P. 83–104. DOI: 10.1196/ annals.1443.023.
34. Rao K.N., Brown M.A. Mast cells: multifaceted immune cells with diverse roles in health and disease // Annals of the New York Academy of Sciences. 2008. Vol. 1143. P. 83–104. DOI: 10.1196/ annals.1443.023.
35. Sayed B.A., Christy A., Quirion M.R., Brown M.A. The master switch: the role of mast cells in autoimmunity and tolerance // Annual Review of Immunology. 2008. Vol. 26. P. 705–739. DOI: 10.1146/annurev.immunol.26.021607.090320.
36. Theoharides T.C., Stewart J.M. Genitourinary mast cells and survival // Transl. Androl. Urol. 2015. Vol. 4, No. 5. P. 579–586. DOI: 10.3978/j.issn.2223-4683.2015.10.04. PMCID: PMC4708553.
37. Walker M.E., Hatfield J.K., Brown M.A. New insights into the role of mast cells in autoimmunity: evidence for a common mechanism of action? // Biochimica et Biophysica Acta – Molecular Basis of Disease. 2012. Vol. 1822, No. 1. P. 57–65. DOI: 10.1016/j. bbadis.2011.02.009.
38. Yunzhi Xu, Guangjie Chen. Mast cell and autoimmune diseases// Mediators Inflamm. 2015. DOI: 10.1155/2015/246126.
39. Zelenika D., Adams E., Humm S. [et al.]. The role of CD4+ T-cell subsets in determining transplantation rejection or tolerance // Immunol. Rev. 2001. Vol. 182. P. 164–179.

PUBLISHER: "MEDITSYNA DV"

Founded in 1997  |  Editions in a year: 4, Articles in one issue: 30 |  ISSN of print version: 1609-1175  |  Ind.: 18410 (Agency "Rospechat’")  |  Edition: 1000 c.